|
|
Medical Devices for vascular access |
|
San Carlos, CA
ABV I |
|
|
|
Safer versions of proven drugs for large chronic disease markets |
|
Fremont, CA
www.aryx.com
ABV I |
|
|
|
Next generation pharmaceuticals for nervous system disorders and cardiovascular disease |
|
Bethlehem, PA
www.azevan.com
ABV I |
|
|
|
Medical devices for vascular and orthopedic diseases |
|
New York, NY
www.biomerix.com
ABV I |
|
|
|
Novel therapeutics to treat human diseases associated with pain and inflammation |
|
Tarrytown, NY
www.caratherapeutics.com
ABV I |
|
|
|
Innovative products for vertebral fracture treatment |
|
New York, NY
Niwot, CO
ABV I |
|
| | |
Medical devices for the treatment of mitral valve regurgitation |
|
Santa Clara, CA
ABV I |
|
| | |
Minimally invasive devices for cardiac rhythm management |
|
Research Triangle Park, NC
www.inner-pulse.com
ABV I |
|
| Metronome | |
Novel oncology drugs |
|
Palo Alto, CA
ABV I |
|
| 
| |
Medical devices for minimally invasive spinal fusion |
|
San Diego, CA
ABV I |
|
|
|
Innovative products for spinal surgery |
|
Redwood City, CA
www.spinalkinetics.com
ABV I |
|
|
|
Minimally invasive direct visualization surgical tool platform, initially for use in spinal procedures |
|
Fremont, CA
ABV II |
|
|
|
Creating disruptive medical device technologies |
|
Durham, NC
Portola Valley, CA
www.synecor.com
ABV I |
|
|
|
Novel therapeutics to treat diseases resulting from oxidative stress-induced protein aging
|
|
Boston, MA
New York, NY
ABV II |
|
|
|
Novel medical devices that enable endoscopic ultrasound-guided translumenal therapy |
|
Mountain View, CA
ABV II |
